Talon Therapeutics, Inc. — Form D
Talon Therapeutics, Inc. of San Mateo, CA, a company, filed a Form D exempt-offering notice with the SEC on 2012-01-13. The offering totals $70.4M, of which $10.3M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2012-01-13
- Form: D
- Accession: 0001181431-12-002537
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $70.4M
- Amount sold: $10.3M
- Remaining: $60.1M
- Investors: 4
- Date of first sale: 2012-01-09
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-171878
Issuer
- Name: Talon Therapeutics, Inc.
- CIK: 0001140028
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Address: 2207 Bridgepointe Parkway, San Mateo, CA, 94404
- Phone: 650-588-6464
Officers, directors & promoters (11)
| Name | Role | Location |
|---|
| Steven R Deitcher, M.D. | Director | San Mateo, CA |
| Andrew P Ferrer | Director | San Mateo, CA |
| Howard P Furst, M.D. | Director | San Mateo, CA |
| Cecilia M Gonzalo | Director | San Mateo, CA |
| Jonathan P Leff | Director | San Mateo, CA |
| Paul V Maier | Director | Deer Park, IL |
| Leon E Rosenberg, M.D. | Director | San Mateo, CA |
| Robert J Spiegel | Director | Berkeley Heights, NJ |
| Craig W Carlson | Executive Officer | San Mateo, CA |
| Steven R Deitcher, M.D. | Executive Officer | San Mateo, CA |
| Samir M Gharib | Executive Officer | San Mateo, CA |
Other filings by this issuer (1)
More